Pearl Secures Record $58M in Dental AI Funding
Pearl, the leading company in dental artificial intelligence, has recently disclosed that it secured $58 million in Series B funding to expedite its goal of enhancing patient care in the field of dentistry. The funding round was spearheaded by Left Lane Capital, with contributions from Smash Capital, Alpha Partners, as well as existing investors Craft Ventures and Neotribe Ventures. This financial backing represents the most substantial investment ever made in dental AI.
This influx of capital will enable Pearl to further progress in developing cutting-edge technologies that promote the well-being of dental patients worldwide. The company aims to achieve this by expanding its range of dental AI products, strengthening its regulatory and patent portfolio, and increasing the global availability of AI benefits in dentistry. Currently, Pearl's machine learning and computer vision tools address a fundamental issue in dentistry: the inconsistency in diagnostic accuracy, which directly impacts patient care quality. The company's AI acts as a real-time assistant to aid dentists in interpreting patient x-rays, providing consistent, objective, and precise diagnoses, and effectively communicating findings to patients with accuracy, clarity, and confidence.
Following its groundbreaking achievement of obtaining FDA clearance for AI software designed to assist dental professionals in identifying various pathologies and conditions in x-rays, Pearl's clinical AI has received regulatory approvals for chairside use in more than 120 countries and has been recognized as one of TIME's Best Inventions. The company intends to utilize the recently announced funding to expedite the continuous enhancement of its computer vision capabilities, including disease detection and tracking in 3D and other imaging modalities, as well as introducing new AI tools to enhance patient treatment planning, streamline insurance claim approvals, and improve dental education.
Comments
Post a Comment